[CITATION][C] Atezolizumab combo approved for PD-L1-positive TNBC. Cancer Discov. 9: OF2. doi: 10.1158/2159-8290

E Dolgin - 2019 - CD-NB2019-038
Save Cite Cited by 3 Related articles